Newer Drug May Prolong Lymphoma Remission
WEDNESDAY, Oct. 4, 2017 -- A newer drug may beat the standard treatment when it comes to battling the blood cancer follicular lymphoma, a clinical trial suggests.
Follicular lymphoma is one type of non-Hodgkin lymphoma, a group of cancers that...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Lymphoma | Non-Hodgkin's Lymphoma